INMUNE BIO INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
INMUNE BIO INC. (INMB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $9.37 million as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2025-08-07
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $9.37M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.22M.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $2.53M.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $10.65M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2025-03-31 | $9.37M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $1.22M 10-Q · filed 2025-08-07 | |
| 2024-09-30 | $2.53M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $10.65M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $23.81M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $21.51M 10-Q · filed 2024-10-31 | |
| 2023-09-30 | $4.89M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $11.69M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $4.36M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $4.16M 10-Q · filed 2023-11-01 | $0.00 10-K · filed 2023-03-02 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $9.03M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $14.41M 10-Q · filed 2022-05-05 | |
| 2021-09-30 | $45.17M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $40.63M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $20.95M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $39.41M 10-Q · filed 2021-11-03 | $39.41M 10-K · filed 2021-03-04 |
| 2020-09-30 | $15.52M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.39M 10-Q · filed 2020-08-05 | |
| 2019-12-31 | $3.37M 10-K · filed 2020-03-11 | |
| 2019-06-30 | $3.18M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |